Conventional lupus nephritis (LN) treatment based on cyclophosphamide, steroids and, recently, mycophenolatemofetil has improved the outcome of the disease over the last 50 years, although failure ...

Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving ...

She completed a year-long training in musculoskeletal ultrasound through the Ultrasound School of North American Rheumatologists ... little is known about recent osteoporotic fracture rates in SLE ...